Ryan White Care Hepatitis C & B Language
NATAP Webinars
Aging in Women Living with HIV
Friday, October 18h, 2024 - 12:30pm
Click here to Register
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial
- (10/30/24)
 
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
 
ID Week:
Predictors of Undetectable HDV RNA 48 Weeks After Completion of Finite Treatment With Bulevirtide and Pegylated-Interferon Alpha-2a
- (10/24/24)
 
ID Week:
Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 144 Interim Analysis of a Phase 3 Randomized Study
- (10/24/24)
 
More Hep D Articles...
 
Aging & Perinatally Acquired HIV
 
AGE:
Incorporating Clinical Geriatrics into HIV care: The Silver Clinic Experience; 'PWH frail 10 years earlier"
- (11/01/24)
 
AGE:
Integrating geriatrics expertise into HIV primary care: The HIV-Endurance (HIVE) Clinic at Boston Medical Center
- (10/31/24)
 
AGE:
Polypharmacy & Deprescribing PWH; Polypharmacy Impact
- (10/31/24)
 
AGE:
Older PWH Loneliness & Facial Emotional Perception Related/Factors; Epigenetic Clock Reflects Coginitve Impairment; Model of Geriatric/Aging Care
- (10/31/24)
 
AGE:
Detecting Brain Structural Changes with Portable Low-Field MRI Among Older People with HIV; Patterns of Brain Atrophy HIV vs without HIV
- (10/31/24)
 
AGE:
Depressive Symptoms are Associated with Cortical Thickness, Regional Brain Volumes, and Cerebral Blood Flow Across Younger and Aging Persons with HIV
- (10/31/24)
 
AGE:
Undiagnosed Sleep Disorders & HIV; Detecting Brain Changes Older PWH with Portable MRI; Depression & Brain Changes; Men with HIV have 42% higher odds of sleep apnea
- (10/31/24)
 
AGE:
Undiagnosed PWH Dementia & Cognitive Impairment Older PWH & Higher Rates
- (10/31/24)
 
AGE:
Clinical & Immunologic Features of People Living with Perinatally Acquired HIV
- (10/31/24)
 
More Aging & HIV Articles...
 
PrEP
 
ID Week:
Implementation and Uptake of Long-acting Injectable PrEP at Atlanta VA Healthcare System
- (10/24/24)
 
ID Week:
Implementation and Uptake of Long-acting Injectable PrEP at Atlanta VA Healthcare System
- (10/24/24)
 
ID Week:
Opportunities for PrEP Awareness and Engagement: A Survey among Cisgender Women Seeking Healthcare in the US
- (10/24/24)
 
ID Week:
Improving HIV Pre-exposure Prophylaxis (PrEP) among Transgender Individuals
- (10/24/24)
 
ID Week:
Integrating PrEP Services into a Gynecology Clinic in Alabama: A Qualitative Analysis of Key Determinants
- (10/24/24)
 
ID Week:
Concerns and opinions of people currently or previously on oral and long acting injectable forms of HIV preexposure prophylaxis (PrEP)
- (10/24/24)
 
ID Week:
Predictors of Undetectable HDV RNA 48 Weeks After Completion of Finite Treatment With Bulevirtide and Pegylated-Interferon Alpha-2a
- (10/24/24)
 
ID Week:
Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 144 Interim Analysis of a Phase 3 Randomized Study
- (10/24/24)
 
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
ID Week:
Should HCV Be Treated in Pregnant Persons?
- (10/24/24)
 
CBO Issues Paper: "A Call for New Research in the Area of Hepatitis C" creates inordinate barrier to HCV elimination
- (08/06/24)
 
CBO Statement: "Budgetary Effects of Policies That Would Increase Hepatitis C Treatment", creates impossible unique barrier to eliminate HCV
- (08/06/24)
 
Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City
- (08/02/24)
 
IAS:
HCV incidence among MSM using HIV PrEP and MSM with HIV in a New York City Health Care System over 2 decades
- (08/02/24)
 
IAS:
Community-Based HCV Self-Testing Widens Testing Access in Big Vietnam Study
- Mark Mascolini (07/27/24)
 
Medicaid Expansion and Restriction Policies for Hepatitis C Treatment
- (07/20/24)
 
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
 
ID Week:
Comparison of Renal Outcomes by Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Containing Regimens for Prevention, and Treatment of HIV and/or HBV Treatment: A Systematic Literature Review and Meta-Analysis
- (10/22/24)
 
ID Week:
High HBV Screening Rate in US Veterans Group With HIV
- Mark Mascolini (10/22/24)
 
ID Week:
HBV HIV Screening Among HIV+ US Veterans Administration
- (10/22/24)
 
ID Week:
Optimizing 2-Drug Switch HBV Screening: pilot intervention to increase HBV screening
- (10/20/24)
 
GSK receives US FDA Fast Track designation for bepirovirsen in chronic hepatitis B
- (08/12/24)
 
IAS:
Efficacy of dolutegravir/lamivudine (DTG/3TC) in adults with HIV-1 and isolated reactive hepatitis B core antibody (anti-HBc): results from the phase 3/3b GEMINI-1/-2, STAT, TANGO, and SALSA
- (07/31/24)
 
Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia - encourages earlier treatment in HBV monoinfection
- (07/10/24)
 
More Hep B Articles...
 
Fatty Liver, NAFLD, NASH
 
2nd New Fatty Liver Drug Pegozafermin in Phase 3
- (08/04/24)
 
Phase 3 Efuxifermin Fatty Liver/MASH Trial Ongoing; EASL 96 weeks HARMONY phase 2b study Results
- (08/04/24)
 
Steatotic liver disease and HIV: an agenda for 2030: 'PWH should be screened for fatty liver, steatosis'
- (07/10/24)
 
EASL:
Identification and validation of pre-identified morphological baseline features for prediction of fibrosis progression in MAESTRO-NASH
- (06/18/24)
 
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
22 February 2024 - 23 February 2024 Nairobi Kenya
https://academicmedicaleducation.com/meeting/african-workshop-hiv-women-2024
May 2-4, 2024 Atlanta, GA
https://acthiv.org/acthiv-2024-program/
https://ddw.org/
https://easl.eu/event/easl-congress-2024/
https://asm.org/Events/ASM-Microbe/Home
Munich, Germany, and virtually from 22 to 26 July 2024.
Pre-conferences will be held on 20 and 21 July.
https://www.iasociety.org/conferences/aids2024
Conference on Liver Disease in Africa (COLDA) 2024
19 September 2024 - 21 September 2024 Egypt
https://academicmedicaleducation.com/meeting/conference-liver-disease-africa-colda-2024
18 September 2024 - 20 September 2024 Liverpool, United Kingdom
https://academicmedicaleducation.com/meeting/international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs-2024
https://www.iasociety.org/conferences/hivr4p2024/registration
https://idweek.org/#
24 October 2024 - 25 October 2024 United States
Washington DC, United States
https://academicmedicaleducation.com/meeting/international-workshop-hiv-aging-2024
10-13 November 2024
https://hivglasgow.org/
San Diego, California
https://www.aasld.org/liver-meeting-tlm-2024
https://informedhorizonseducation.com/hiv-respidart-2024